GOSS Gossamer Bio Corp.: Net earnings per share for the last 12 months

Public company logo of Gossamer Bio Inc (GOSS)

Gossamer Bio, Inc. (GOSS) is developing seralotinib, utilizing an inhalation method for the targeted treatment of pulmonary hypertension. The application of AI algorithms in formula discovery and synthesis automation drive the 12-month EPS growth dynamics, where the current mark is 34.30. The company's success and future sales depend on the completion of Phase 3 trials and regulatory approval of the drug.

GOSS Gossamer Bio Inc Earnings per share for the last twelve months (02/11/2024 - 11/14/2026)

Gossamer Bio Corp. - analytical breakdowns and key metrics (GOSS)

- market value and analyst target forecast:
Stock Quotes Gossamer Bio Inc|GOSS - Price Target Chart
- company stock capitalization data:
Market Valuation Gossamer Bio|GOSS - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Gossamer Bio|GOSS - Company Book Value|Capitalization to Book Value Ratio gossamerbio.com|GOSS - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Gossamer Bio, Inc.|GOSS - Long-Term Debt to Capital|Short-Term Indebtedness to Equity gossamerbio.com|GOSS - Company Debts|Debts to Book Value Gossamer Bio Corp.|GOSS - Company Long-Term Debt|Short-Term Debt Volume Gossamer Bio|Interim Coverage Ratio gossamerbio.com
- earnings and multiples data:
GOSS - Net Profit|Projected Future Earnings Gossamer Bio, Inc.|GOSS - Price to Earnings Ratio|Projected Price to Earnings Gossamer Corp|GOSS - PEG Multiple|Company Value to EBITDA Gossamer Bio Corp.|GOSS - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Gossamer Bio|GOSS - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months gossamerbio.com|GOSS - Earnings growth in current year|Net earnings per share growth forecast for next year Gossamer Bio, Inc.
- revenue and sales details:
GOSS - Revenue and Sales Volume|Company Future Sales Gossamer Bio Inc|GOSS - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Gossamer Bio
Initial company analysis:GOSS, Gossamer Bio Inc
Core merchandise of Gossamer Corp

The effectiveness of the clinical strategy adaptation at Gossamer Bio, Inc. (GOSS) correlates directly with net earnings per share dynamics. By analyzing the current YoY EPS shift over the last 12 months, an investor can observe the percentage change in rolling annual income, allowing for an objective assessment of the biotech's financial stability and real progress in the development of its key drug, regardless of quarterly fluctuations.

Competitor analysis

argenx N.V. (ARGX) - Net earnings per share for the last 12 months|BioNTech Pharma (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) protagonist-inc.com|Earnings per share for the last twelve months Immunovant Corp (IMVT)|Kiniksa - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (grifols.com)|Adaptive Biotechnologies Corp (ADPT) - Net earnings per one share for the last twelve months|celldex.com - Net earnings per share (EPS TTM)|AUPH - Net earnings per share (EPS TTM)|BCRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Vera Therapeutics Inc (VERA)|DNTH (Dianthus Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Pharvaris Pharma|Net earnings per share (EPS TTM) ABCL|TRML (tourmalinebio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PGEN (Precigen Inc)|PHAR - Net earnings per share for the last 12 months|NKTR - Earnings per share for the last twelve months|UPB - Net earnings per share (EPS TTM)|ZBIO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Immunome, Inc.|KALV (kalvista.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Septerna Corp|Net earnings per share (EPS TTM) PVLA|Savara Corp - Earnings per share for the last 12 months|Earnings per share for the last twelve months Rigel Pharmaceuticals RIGL|AnaptysBio (ANAB) - Net earnings per one share for the last twelve months|ATXS - Earnings per share for the last twelve months|ENGN (enGene) - Earnings per share for the last 12 months|RAPT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aerovate (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) kyvernatx.com|Earnings per share for the last twelve months Tiziana Life Sciences Ltd. (TLSA)|CABA (Cabaletta Bio) - Earnings per share for the trailing year|Earnings per share for the last twelve months Ventyx Biosciences VTYX|Net earnings per share for the last four quarters Theratechnologies Inc (THTX)|avalotx.com - Net earnings per share (EPS TTM)|ELDN - Net earnings per share (EPS TTM)|AGEN (Agenus Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Climb Bio Inc.|Net earnings per share for the last 12 months ZURA|ATYR (aTyr Pharma, Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ImageneBio (IMA)|Shattuck Labs - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) equilliumbio.com EQ|connectbiopharm.com - Net earnings per share (EPS TTM)|immunic-therapeutics.com (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|InflaRx N.V. (IFRX) - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months x4pharma.com XFOR|Net earnings per share for the last 12 months adicetbio.com (ACET)|Earnings per share for the last twelve months Celularity Inc (CELU)|Net earnings per share for the last 12 months INmune Bio Corp INMB|Earnings per share for the last twelve months barinthusbio.com BRNS|Earnings per share for the trailing year KZR|sabbiotherapeutics.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AKTX (Akari Therapeutics PLC)|ENLV: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months QTTB|GOVX (geovax.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Edesa Biotech|Net earnings per share (EPS TTM) IBIO|Net earnings per share for the last 12 months Carisma Therapeutics Inc. CARM|Earnings per share for the last twelve months XTL Biopharmaceuticals, Ltd. XTLB|Net earnings per share (EPS TTM) boltbio.com BOLT|HCWB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. (AIM) - Earnings per share for the last twelve months|ADTX: Earnings per share for the last four quarters|GRI (GRI Bio Corporation) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) XORTX Therapeutics Inc.|Earnings per share for the last twelve months Vyome Holdings (HIND)|Net earnings per share for the last four quarters revbiosciences.com|Earnings per share for the last twelve months Indaptus Therapeutics Inc INDP|Net earnings per share (EPS TTM) Scinai SCNI|CALI - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AFMD|ALLK (Allakos Therapeutics) - Net earnings per share for the last 12 months|HOOKIPA - Earnings per share for the trailing year|IGMS (IGM Biosciences) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months iTeos Therapeutics Inc ITOS|Earnings per share for the last twelve months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TC Biopharm TCBP|Net earnings per share (EPS TTM) THRD (Third Harmonic Bio, Inc.)